Movement Alert｜Boston Scientific Falls 3.04% in Regular Trading, Ongoing Cybersecurity Probe and FDA Highest-Severity Catheter Recall Weigh on Shares

Market Focus03:05

On September 4, Boston Scientific fell 3.04% in regular trading, trading at $46.86/share, with turnover of $581 million. The stock had previously rebounded to near pre-incident levels but has pulled back again amid lingering dual headwinds.

On the news front, the cybersecurity incident first disclosed on August 25 remains under active investigation, with no confirmed timeline for full system restoration. The company stated it is unable to determine whether the incident will have a material impact on operations, as access to certain IT systems and business applications continues to be disrupted, limiting customer order processing and product shipments across multiple markets. The company has engaged third-party cybersecurity experts to assess and contain the threat.

Compounding the pressure, the FDA has classified the recall of certain lots of Boston Scientific's ENROUTE Transcarotid Neuroprotection System devices at its highest severity level, citing risks of arterial sheath tip separation that could lead to embolism and stroke. One serious injury has been reported in connection with the issue.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190247340?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 03:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190247340","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Falls 3.04% in Regular Trading, Ongoing Cybersecurity Probe and FDA Highest-Severity Catheter Recall Weigh on Shares","media":"Market Focus","content":"<p><p>On September 4, Boston Scientific fell 3.04% in regular trading, trading at $46.86/share, with turnover of $581 million. The stock had previously rebounded to near pre-incident levels but has pulled back again amid lingering dual headwinds.</p><p>On the news front, the cybersecurity incident first disclosed on August 25 remains under active investigation, with no confirmed timeline for full system restoration. The company stated it is unable to determine whether the incident will have a material impact on operations, as access to certain IT systems and business applications continues to be disrupted, limiting customer order processing and product shipments across multiple markets. The company has engaged third-party cybersecurity experts to assess and contain the threat.</p><p>Compounding the pressure, the FDA has classified the recall of certain lots of Boston Scientific's ENROUTE Transcarotid Neuroprotection System devices at its highest severity level, citing risks of arterial sheath tip separation that could lead to embolism and stroke. One serious injury has been reported in connection with the issue.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Falls 3.04% in Regular Trading, Ongoing Cybersecurity Probe and FDA Highest-Severity Catheter Recall Weigh on Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Falls 3.04% in Regular Trading, Ongoing Cybersecurity Probe and FDA Highest-Severity Catheter Recall Weigh on Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-04 03:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 4, Boston Scientific fell 3.04% in regular trading, trading at $46.86/share, with turnover of $581 million. The stock had previously rebounded to near pre-incident levels but has pulled back again amid lingering dual headwinds.</p><p>On the news front, the cybersecurity incident first disclosed on August 25 remains under active investigation, with no confirmed timeline for full system restoration. The company stated it is unable to determine whether the incident will have a material impact on operations, as access to certain IT systems and business applications continues to be disrupted, limiting customer order processing and product shipments across multiple markets. The company has engaged third-party cybersecurity experts to assess and contain the threat.</p><p>Compounding the pressure, the FDA has classified the recall of certain lots of Boston Scientific's ENROUTE Transcarotid Neuroprotection System devices at its highest severity level, citing risks of arterial sheath tip separation that could lead to embolism and stroke. One serious injury has been reported in connection with the issue.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1190247340","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190247340","pubTimestamp":1788462356,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 4, Boston Scientific fell 3.04% in regular trading, trading at $46.86/share, with turnover of $581 million. The stock had previously rebounded to near pre-incident levels but has pulled...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"走势警报|波士顿科学公司常规交易下跌 3.04%，正在进行的网络安全调查和 FDA 最严重的导管召回令股价承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On September 4, Boston Scientific fell 3.04% in regular trading, trading at $46.86/share, with turnover of $581 million. The stock had previously rebounded to near pre-incident levels but has pulled back again amid lingering dual headwinds.On the news front, the cybersecurity incident first disclosed on August 25 remains under active investigation, with no confirmed timeline for full system restoration. The company stated it is unable to determine whether the incident will have a material impact on operations, as access to certain IT systems and business applications continues to be disrupted, limiting customer order processing and product shipments across multiple markets. The company has engaged third-party cybersecurity experts to assess and contain the threat.Compounding the pressure, the FDA has classified the recall of certain lots of Boston Scientific's ENROUTE Transcarotid Neuroprotection System devices at its highest severity level, citing risks of arterial sheath tip separation that could lead to embolism and stroke. One serious injury has been reported in connection with the issue.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190247340","isCrawlerRequest":true}